Your browser doesn't support javascript.
loading
Differential Influence of Donor Age Depending on the Indication for Liver Transplantation-A Collaborative Transplant Study Report.
Houben, Philipp; Döhler, Bernd; Weiß, Karl H; Mieth, Markus; Mehrabi, Arianeb; Süsal, Caner.
Afiliação
  • Houben P; Department of General, Visceral, and Transplant Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Döhler B; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Weiß KH; Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany.
  • Mieth M; Department of General, Visceral, and Transplant Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Mehrabi A; Department of General, Visceral, and Transplant Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Süsal C; Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Transplantation ; 104(4): 779-787, 2020 04.
Article em En | MEDLINE | ID: mdl-32224813
ABSTRACT

BACKGROUND:

Despite steadily increasing donor age, there are no general guidelines for the use of organs from elderly donors in liver transplantation. This study focuses on identifying the recipients who are less affected from an old-donor organ graft and conversely in whom a rather unfavorable outcome is expected because of high donor age.

METHODS:

Forty-eight thousand two hundred sixty-one adult liver transplantations, performed between 2000 and 2017 and reported to the Collaborative Transplant Study, were analyzed.

RESULTS:

The proportion of ≥65-year-old donors has risen to >33% in recent years. The donor age has an approximately linear influence on graft survival. On average, each year's rise in the donor age was associated with a 0.9% increase in the risk of graft loss (hazard ratio [HR], 1.009; P < 0.001). The impact of donor age was strong in patients with hepatitis C-related cirrhosis (HR, 1.013; P < 0.001), substantial in patients with alcoholic cirrhosis (HR, 1.007; P < 0.001) and rather weak in patients with hepatocellular carcinoma (HR, 1.003; P = 0.038). The increase in the risk of graft loss per year rise in donor age was 1.4% for 18 to 49 year olds, 1.0% for middle-aged, and only 0.4% for ≥60-year-old recipients (all P < 0.001).

CONCLUSIONS:

Consequently, older recipients and especially patients with hepatocellular carcinoma seem to be less affected by an increased donor age, whereas the donor age is an important factor in all other patient groups.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Seleção do Doador Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Seleção do Doador Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article